EMRO Secures U.S. Patent Registration for Its Proprietary AI Technology

- Proprietary AI-based procurement item data similarity analysis and automated classification technology secures U.S. patent, following Korea and Japan

- AI technology specialized for procurement recognized in the U.S., the world’s largest enterprise software market, reinforcing global competitiveness

- Expected to accelerate overseas customer expansion and fuel global growth momentum

June 4, 2024 – Emro Inc. (KOSDAQ: 058970), Korea’s leading AI-based SRM software company, announced today that its proprietary AI technology has been granted a patent by the United States Patent and Trademark Office (USPTO).

The newly granted patent, titled “Method and Apparatus for Providing Information Using a Learning Model Based on Machine Learning,” utilizes AI-based Natural Language Processing (NLP) technology to analyze similarities among massive volumes of item data registered in corporate procurement systems and automatically classify them. Emro already holds related patents for this technology in both Korea and Japan.

The patented technology has been commercialized through Emro’s AI software solution, SMART Item Doctor, which is currently used by leading Korean enterprises across a wide range of industries, including Hyundai Motor Company, Korean Air, HD Hyundai Oilbank, Hanwha Construction, Hyundai Steel, and POSCO DX. Through these deployments, Emro has been spearheading digital transformation in procurement operations.

As companies worldwide increasingly seek to apply AI technologies to core business functions to enhance productivity and operational efficiency, Emro’s AI-based SRM software is drawing strong interest not only in the domestic market but also overseas. With this U.S. patent registration, Emro’s AI capabilities specialized for procurement have been officially recognized in the United States—the world’s largest and most technologically advanced enterprise software market—further strengthening expectations for accelerated market penetration and business expansion.

An Emro official commented, “The United States, where this patent has been registered, is our primary target market for global expansion, and we are currently conducting active sales and marketing activities in collaboration with Samsung SDS.” The official added, “By leveraging Emro’s advanced AI technology and extensive implementation track record, we aim to secure local customers and rapidly establish a strong presence in the global market.”